Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies

W. M. Vollmer, A (Sonia) Buist, L. R. Johnson, L. E. McCamant, M. Halonen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Evidence is accumulating that elevated levels of serum IgE may play a role in the pathogenesis of chronic airflow obstruction. We examined this question using data on 863 subjects drawn from two cohort studies which we have followed over a period of nine to 11 years. One, the Portland cohort, represents a working population aged 25 to 55 years at baseline. The second, the Screening Center cohort, spans a wider age range (18 to 87 years at baseline) and is biased towards respiratory disease. Spirometric tests and respiratory symptom questionnaires have been administered five times over a nine-year period for the Portland cohort, and over an 11-year period for the Screening Center cohort. IgE was measured one time towards the end of the follow-up. Our data confirm the finding that smokers tend to have higher IgE levels than nonsmokers. For the combined sample, geometric mean levels of IgE were 31.0 IU/ml among smokers and 17.4 IU/ml among nonsmokers. Levels among ex-smokers were intermediate. Among smokers, IgE was not related to either amount smoked or pack-years. Cross-sectionally, FEV1 was inversely related to IgE in the Screening Center cohort, but not in the Portland cohort study. Among smokers, this association was only present for those subjects with symptoms of chronic bronchitis (chronic cough/sputum production). We found no association of IgE with longitudinal rate of decline of FEV1 in either cohort. These findings are consistent with other studies and support the hypothesis that serum IgE is inversely related to function level cross-sectionally, but is not predictive of rate of decline of lung function.

Original languageEnglish (US)
Pages (from-to)416-423
Number of pages8
JournalChest
Volume90
Issue number3
StatePublished - 1986

Fingerprint

Immunoglobulin E
Cohort Studies
Serum
Chronic Bronchitis
Sputum
Cough
Chronic Obstructive Pulmonary Disease
Lung
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Vollmer, W. M., Buist, A. S., Johnson, L. R., McCamant, L. E., & Halonen, M. (1986). Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies. Chest, 90(3), 416-423.

Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies. / Vollmer, W. M.; Buist, A (Sonia); Johnson, L. R.; McCamant, L. E.; Halonen, M.

In: Chest, Vol. 90, No. 3, 1986, p. 416-423.

Research output: Contribution to journalArticle

Vollmer, WM, Buist, AS, Johnson, LR, McCamant, LE & Halonen, M 1986, 'Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies', Chest, vol. 90, no. 3, pp. 416-423.
Vollmer, W. M. ; Buist, A (Sonia) ; Johnson, L. R. ; McCamant, L. E. ; Halonen, M. / Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies. In: Chest. 1986 ; Vol. 90, No. 3. pp. 416-423.
@article{b8ec8fc040a346eebaa4108e863169ec,
title = "Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies",
abstract = "Evidence is accumulating that elevated levels of serum IgE may play a role in the pathogenesis of chronic airflow obstruction. We examined this question using data on 863 subjects drawn from two cohort studies which we have followed over a period of nine to 11 years. One, the Portland cohort, represents a working population aged 25 to 55 years at baseline. The second, the Screening Center cohort, spans a wider age range (18 to 87 years at baseline) and is biased towards respiratory disease. Spirometric tests and respiratory symptom questionnaires have been administered five times over a nine-year period for the Portland cohort, and over an 11-year period for the Screening Center cohort. IgE was measured one time towards the end of the follow-up. Our data confirm the finding that smokers tend to have higher IgE levels than nonsmokers. For the combined sample, geometric mean levels of IgE were 31.0 IU/ml among smokers and 17.4 IU/ml among nonsmokers. Levels among ex-smokers were intermediate. Among smokers, IgE was not related to either amount smoked or pack-years. Cross-sectionally, FEV1 was inversely related to IgE in the Screening Center cohort, but not in the Portland cohort study. Among smokers, this association was only present for those subjects with symptoms of chronic bronchitis (chronic cough/sputum production). We found no association of IgE with longitudinal rate of decline of FEV1 in either cohort. These findings are consistent with other studies and support the hypothesis that serum IgE is inversely related to function level cross-sectionally, but is not predictive of rate of decline of lung function.",
author = "Vollmer, {W. M.} and Buist, {A (Sonia)} and Johnson, {L. R.} and McCamant, {L. E.} and M. Halonen",
year = "1986",
language = "English (US)",
volume = "90",
pages = "416--423",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",

}

TY - JOUR

T1 - Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies

AU - Vollmer, W. M.

AU - Buist, A (Sonia)

AU - Johnson, L. R.

AU - McCamant, L. E.

AU - Halonen, M.

PY - 1986

Y1 - 1986

N2 - Evidence is accumulating that elevated levels of serum IgE may play a role in the pathogenesis of chronic airflow obstruction. We examined this question using data on 863 subjects drawn from two cohort studies which we have followed over a period of nine to 11 years. One, the Portland cohort, represents a working population aged 25 to 55 years at baseline. The second, the Screening Center cohort, spans a wider age range (18 to 87 years at baseline) and is biased towards respiratory disease. Spirometric tests and respiratory symptom questionnaires have been administered five times over a nine-year period for the Portland cohort, and over an 11-year period for the Screening Center cohort. IgE was measured one time towards the end of the follow-up. Our data confirm the finding that smokers tend to have higher IgE levels than nonsmokers. For the combined sample, geometric mean levels of IgE were 31.0 IU/ml among smokers and 17.4 IU/ml among nonsmokers. Levels among ex-smokers were intermediate. Among smokers, IgE was not related to either amount smoked or pack-years. Cross-sectionally, FEV1 was inversely related to IgE in the Screening Center cohort, but not in the Portland cohort study. Among smokers, this association was only present for those subjects with symptoms of chronic bronchitis (chronic cough/sputum production). We found no association of IgE with longitudinal rate of decline of FEV1 in either cohort. These findings are consistent with other studies and support the hypothesis that serum IgE is inversely related to function level cross-sectionally, but is not predictive of rate of decline of lung function.

AB - Evidence is accumulating that elevated levels of serum IgE may play a role in the pathogenesis of chronic airflow obstruction. We examined this question using data on 863 subjects drawn from two cohort studies which we have followed over a period of nine to 11 years. One, the Portland cohort, represents a working population aged 25 to 55 years at baseline. The second, the Screening Center cohort, spans a wider age range (18 to 87 years at baseline) and is biased towards respiratory disease. Spirometric tests and respiratory symptom questionnaires have been administered five times over a nine-year period for the Portland cohort, and over an 11-year period for the Screening Center cohort. IgE was measured one time towards the end of the follow-up. Our data confirm the finding that smokers tend to have higher IgE levels than nonsmokers. For the combined sample, geometric mean levels of IgE were 31.0 IU/ml among smokers and 17.4 IU/ml among nonsmokers. Levels among ex-smokers were intermediate. Among smokers, IgE was not related to either amount smoked or pack-years. Cross-sectionally, FEV1 was inversely related to IgE in the Screening Center cohort, but not in the Portland cohort study. Among smokers, this association was only present for those subjects with symptoms of chronic bronchitis (chronic cough/sputum production). We found no association of IgE with longitudinal rate of decline of FEV1 in either cohort. These findings are consistent with other studies and support the hypothesis that serum IgE is inversely related to function level cross-sectionally, but is not predictive of rate of decline of lung function.

UR - http://www.scopus.com/inward/record.url?scp=0022459256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022459256&partnerID=8YFLogxK

M3 - Article

C2 - 3488877

AN - SCOPUS:0022459256

VL - 90

SP - 416

EP - 423

JO - Chest

JF - Chest

SN - 0012-3692

IS - 3

ER -